Almirall SA

Almirall UK is the British subsidiary of the Spanish pharmaceutical company Almirall, focused exclusively on medical dermatology. The company develops and markets innovative prescription treatments for chronic and serious skin diseases including psoriasis, acne, atopic dermatitis, actinic keratosis, and rosacea. Key products include Skilarence (dimethyl fumarate) for moderate-to-severe plaque psoriasis and Ebglyss (lebrikizumab) for atopic dermatitis. Almirall UK works closely with NHS dermatology departments and consultant dermatologists.